Relapsed chronic lymphocytic leukemia with a cardiac mass: A case report
Amir A Mahmoud1, Ali Abdelhay1, Mariam Mostafa1
1Department of Medicine, Rochester General Hospital, 1425 Portland Ave, New York, NY 14621, USA.
Radiology Case Reports
|March 27, 2023
Summary
This case report details an extremely rare instance of cardiac involvement in chronic lymphocytic leukemia (CLL). A patient in remission presented with a large cardiac mass, highlighting the need for further research into extramedullary CLL.
Area of Science:
- Hematology
- Oncology
- Cardiology
Background:
- Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in the USA.
- Extramedullary disease in CLL is rare and poorly understood.
- Clinically significant cardiac or pericardial involvement by CLL is exceptionally uncommon, with limited case reports.
Observation:
- A 51-year-old male with a history of CLL in remission presented with symptoms including fatigue, dyspnea, night sweats, and lymphadenopathy.
- Imaging revealed a large soft tissue mass in the right atrium and ventricle, with suspected pericardial involvement and enlarged lymph nodes.
- Cardiac imaging confirmed a substantial infiltrating mass extending into the inferior vena cava and coronary sinus.
Findings:
- Histopathology of a lymph node biopsy confirmed Small Lymphocytic Lymphoma (SLL)/CLL.
- This case represents one of the few documented instances of cardiac extramedullary-CLL presenting as an isolated cardiac mass.
- The findings underscore the potential for rare presentations of CLL.
Implications:
- This case highlights the importance of considering rare extramedullary manifestations of CLL, even in patients with previously treated disease.
- Further research is necessary to elucidate the disease course, prognosis, and optimal management strategies for cardiac extramedullary CLL.
- The role of surgical intervention in such cases requires further investigation.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
14
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy
18
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Cardiomyopathy I: Introduction and Classification
26
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Cardiomyopathy II: Dilated Cardiomyopathy
14
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Cardiomyopathy VI: Nursing Management
21
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
21
Myocarditis III: Medical Management
10
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
10


